<DOC>
	<DOCNO>NCT00357019</DOCNO>
	<brief_summary>To assess clinical biological efficacity preservative free NAAGA eye drop vernal keratoconjunctivitis</brief_summary>
	<brief_title>Study Clinical Biological Efficacity NAAXIA SINE® Vernal Keratoconjunctivitis</brief_title>
	<detailed_description>The objective pilot study evaluate clinical biological efficacy preservative free NAAGA eyedrops VKC –by particular level ECP MPO tears- comparatively activity levocabastine eyedrop .</detailed_description>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>N-acetyl-1-aspartylglutamic acid</mesh_term>
	<criteria>Patients vernal keratoconjunctivitis , mild moderate : clinical score &gt; 3 &lt; = 14 , calculate 4 major symptom ( itch , tear , photophobia , foreign body sensation ) 6 major clinical sign ( conjunctival erythema , conjunctival chemosis , discharge , papilla , limbal infiltrates corneal epithelial disease ) age &gt; = 4 year old occurrence ocular trauma infection ( within 3 month precede study ) , ocular medical treatment ( topical ) within 5 day precede study , ocular laser ( within 3 previous month ) , ocular surgery ( within previous year ) , patient sign inform consent form ( his/her parent legal guardian case underage patient ) .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>